首页> 外文期刊>Urologic oncology >The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional study11This work was supported in part by Grants-in-Aid for Scientific Research (#24791671 to Tanaka N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
【24h】

The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: A multi-institutional study11This work was supported in part by Grants-in-Aid for Scientific Research (#24791671 to Tanaka N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

机译:尿液细胞学检查阳性对原发性上尿路尿路上皮癌患者根治性肾结直肠癌切除术后结局的预测价值:一项多机构研究11这项工作部分得到了美国资助的科学研究补助金(田中N.的#24791671)的支持。日本教育,文化,体育,科学和技术省。

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objective: Few studies have addressed the predictive value of positive urine cytology for prognosis in patients with upper tract urothelial carcinoma (UTUC). We investigated whether the status of preoperative urine cytology could provide additional prognostic information following radical nephroureterectomy (RNU). Materials and methods: The study included 474 patients with primary nonmetastatic UTUC (pTa-4N0M0) from a retrospective multi-institutional cohort. The median follow-up period was 35 months. Associations between the status of urine cytologic evaluation and outcomes were analyzed using multivariate Cox regression models. Urine cytology was evaluated preoperatively using voided samples. Disease recurrence was defined as any relapse in nonbladder lesions and was coded separately from intravesical recurrence. Results: Positive urine cytology was detected in 184 patients (38.8%) preoperatively. Disease recurrence occurred in 127 patients, while intravesical recurrence occurred in 219 patients; 83 patients died of UTUC during follow-up. Kaplan-Meier analysis revealed that only the incidence of intravesical recurrence was significantly associated with the status of urine cytologic evaluation (P = 0.024); the intravesical recurrence-free survival rates at 1 and 3 years following RNU were 61.4% and 46.2% in patients with positive urine cytology and 71.1% and 51.6% in their counterparts, respectively. Multivariate analysis showed that gender (hazard ratio [HR] = 1.74, 95% confidence interval [CI]; 1.28-2.43), tumor multifocality in RNU specimens (HR = 1.64, 95% CI; 1.09-2.47), and positive urine cytology (HR = 1.41, 95% CI; 1.08-1.85) were independent risk factors for subsequent intravesical recurrence. Conclusions: The results showed the prognostic value of positive urine cytology in patients with primary UTUC, and preoperative positive urine cytology may be associated with a significant increase in the prevalence of intravesical recurrence following RNU.
机译:背景与目的:很少有研究探讨尿液细胞学检查阳性对上尿路尿路上皮癌(UTUC)患者预后的预测价值。我们调查了根治性肾切除术(RNU)后,术前尿液细胞学检查的状况是否可以提供其他预后信息。材料和方法:该研究包括来自回顾性多机构队列的474例原发性非转移性UTUC(pTa-4N0M0)患者。中位随访期为35个月。使用多变量Cox回归模型分析了尿液细胞学评估状态与结果之间的关联。术前使用无效样本评估尿液细胞学。疾病复发定义为非膀胱病变的任何复发,并与膀胱内复发分开编码。结果:术前184例患者(38.8%)尿液细胞学检查阳性。 127例患者发生疾病复发,而219例患者发生膀胱内复发;随访期间83例患者死于UTUC。 Kaplan-Meier分析显示,只有膀胱内复发的发生与尿液细胞学评估的状态显着相关(P = 0.024)。尿液细胞学检查阳性的患者,RNU后1年和3年的膀胱内无复发生存率分别为61.4%和46.2%,其对应者为71.1%和51.6%。多因素分析表明,性别(危险比[HR] = 1.74,95%置信区间[CI]; 1.28-2.43),RNU标本中的肿瘤多灶性(HR = 1.64、95%CI; 1.09-2.47)和尿液细胞学阳性(HR = 1.41,95%CI; 1.08-1.85)是随后膀胱内复发的独立危险因素。结论:结果显示阳性尿细胞学检查对原发性UTUC患者的预后价值,术前阳性尿细胞学检查可能与RNU术后膀胱内复发的发生率显着增加有关。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号